Bid Publish Date
30-Apr-2025, 1:11 pm
Bid End Date
21-May-2025, 2:00 pm
EMD
₹19,656
Location
Progress
RAQuantity
5286
Bid Type
Two Packet Bid
Indian Army announces a tender for Inj Nano Liposomal Docetaxel vial of 20 mg, Isavuconazole 100 mg Cap, POMALIDOMIDE 4 MG TAB, Darbepoietin 500 mcg inj, CHLORHEXIDINE GLUCONATE 2 percent IN 70 percent ISOPROPYL ALCOHOL 500 ML BOTT, 10percentE IODINE SOLUTION USP EQUIVALENT TO 1 percent AVAILABLE IODINE 500 ML BOTT, Omalizumab 150mg solution for injection in each 1 ml Pre Filled Syringe PFS in PUNE, MAHARASHTRA. Quantity: 5286. Submission Deadline: 21-05-2025 14: 00: 00. Last date to apply is approaching fast!
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Item Category
Inj Nano Liposomal Docetaxel vial of 20 mg , Isavuconazole 100 mg Cap , POMALIDOMIDE 4 MG TAB , Darbepoietin 500 mcg inj , CHLORHEXIDINE GLUCONATE 2 percent IN 70 percent ISOPROPYL ALCOHOL 500 ML BOTT , 10percentE IODINE SOLUTION USP EQUIVALENT TO 1 percent AVAILABLE IODINE 500 ML BOTT , Omalizumab 150mg solution for injection in each 1 ml Pre Filled Syringe PFS
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Inj Nano Liposomal Docetaxel vial of 20 mg
Inj Nano Liposomal Docetaxel vial of 20 mg
Isavuconazole 100 mg Cap
Isavuconazole 100 mg Cap
POMALIDOMIDE 4 MG TAB
POMALIDOMIDE 4 MG TAB
Darbepoietin 500 mcg inj
Darbepoietin 500 mcg inj
CHLORHEXIDINE GLUCONATE 2 percent IN 70 percent ISOPROPYL ALCOHOL 500 ML BOTT
CHLORHEXIDINE GLUCONATE 2 percent IN 70 percent ISOPROPYL ALCOHOL 500 ML BOTT
10percentE IODINE SOLUTION USP EQUIVALENT TO 1 percent AVAILABLE IODINE 500 ML BOTT
10percentE IODINE SOLUTION USP EQUIVALENT TO 1 percent AVAILABLE IODINE 500 ML BOTT
Omalizumab 150mg solution for injection in each 1 ml Pre Filled Syringe PFS
Omalizumab 150mg solution for injection in each 1 ml Pre Filled Syringe PFS
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Inj Nano Liposomal Docetaxel vial of 20 mg | Inj Nano Liposomal Docetaxel vial of 20 mg | 60 | amp vial | [email protected] | 30 | |
| 2 | Isavuconazole 100 mg Cap | Isavuconazole 100 mg Cap | 168 | no | [email protected] | 30 | |
| 3 | POMALIDOMIDE 4 MG TAB | POMALIDOMIDE 4 MG TAB | 1,200 | no | [email protected] | 30 | |
| 4 | Darbepoietin 500 mcg inj | Darbepoietin 500 mcg inj | 21 | vial | [email protected] | 30 | |
| 5 | CHLORHEXIDINE GLUCONATE 2 percent IN 70 percent ISOPROPYL ALCOHOL 500 ML BOTT | CHLORHEXIDINE GLUCONATE 2 percent IN 70 percent ISOPROPYL ALCOHOL 500 ML BOTT | 1,878 | bott | [email protected] | 30 | |
| 6 | 10percentE IODINE SOLUTION USP EQUIVALENT TO 1 percent AVAILABLE IODINE 500 ML BOTT | 10percentE IODINE SOLUTION USP EQUIVALENT TO 1 percent AVAILABLE IODINE 500 ML BOTT | 1,881 | bott | [email protected] | 30 | |
| 7 | Omalizumab 150mg solution for injection in each 1 ml Pre Filled Syringe PFS | Omalizumab 150mg solution for injection in each 1 ml Pre Filled Syringe PFS | 78 | pfs | [email protected] | 30 |
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Start
06-Jun-2025, 1:00 pm
End
07-Jun-2025, 1:00 pm
Duration: 24 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 21-05-2025 13:41:50 | |
| 2 | ********** Under PMA | - | 20-05-2025 18:44:26 | |
| 3 | ********** Under PMA | - | 21-05-2025 12:53:07 | |
| 4 | ********** Under PMA | - | 21-05-2025 13:03:16 | |
| 5 | ********** Under PMA | - | 17-05-2025 22:13:33 | |
| 6 | ********** Under PMA | - | 21-05-2025 13:40:54 | |
| 7 | ********** Under PMA | - | 21-05-2025 13:05:03 | |
| 8 | ********** Under PMA | - | 19-05-2025 14:41:35 | |
| 9 | ********** Under PMA | - | 21-05-2025 12:23:15 | |
| 10 | ********** Under PMA | - | 20-05-2025 22:24:02 | |
| 11 | ********** Under PMA | - | 16-05-2025 17:39:14 | |
| 12 | ********** Under PMA | - | 14-05-2025 11:27:07 | |
| 13 | ********** Under PMA | - | 20-05-2025 19:37:35 | |
| 14 | ********** Under PMA | - | 20-05-2025 15:48:20 | |
| 15 | ********** Under PMA | - | 01-05-2025 17:47:58 | |
| 16 | ********** Under PMA | - | 20-05-2025 20:40:00 | |
| 17 | ********** Under PMA | - | 20-05-2025 12:15:23 | |
| 18 | ********** Under PMA | - | 20-05-2025 19:09:40 | |
| 19 | ********** Under PMA | - | 21-05-2025 13:02:12 | |
| 20 | ********** Under PMA | - | 12-05-2025 11:22:57 | |
| 21 | ********** Under PMA | - | 21-05-2025 12:29:24 | |
| 22 | ********** Under PMA | - | 07-05-2025 16:12:40 |
Key insights about MAHARASHTRA tender market
The eligibility requirements include being a registered entity with the relevant government authorities, adequate compliance with pharmaceutical regulations, and a successful track record of handling similar supply contracts. Bidders must also possess the necessary certifications that validate their operational capabilities in supplying medical products.
Bidders need to provide various required certificates to participate effectively in the tender, including registration as a pharmaceutical supplier, quality assurance certifications (such as ISO), and any other relevant licenses issued by health authorities. All certificates should be current and valid.
To complete the registration process, interested bidders must access the official procurement portal, create an account, and submit the necessary documentation online. Ensure all required fields are filled out accurately, and all supporting documents are uploaded in the accepted formats to avoid disqualification.
The submission must be made in standard document formats, typically including PDF and Word formats. Bid pricing should be presented in an Excel sheet as specified in the tender documentation, ensuring clarity and easy assessment.
MSEs are provided with specific benefits as part of the tendering process. These may include reduced eligibility criteria and potential assistance during the bidding step, aimed at promoting local businesses. Compliance with the government's Make in India initiative is encouraged, promoting local sourcing and procurement rules.
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS